Gold nanoparticle approach to the selective delivery of gene silencing in cancer-The case for combined delivery?

Research output: Contribution to journalReview article

25 Citations (Scopus)


Gene therapy arises as a great promise for cancer therapeutics due to its potential to silence genes involved in tumor development. In fact, there are some pivotal gene drivers that suffer critical alterations leading to cell transformation and ultimately to tumor growth. In this vein, gene silencing has been proposed as an active tool to selectively silence these molecular triggers of cancer, thus improving treatment. However, naked nucleic acid (DNA/RNA) sequences are reported to have a short lifetime in the body, promptly degraded by circulating enzymes, which in turn speed up elimination and decrease the therapeutic potential of these drugs. The use of nanoparticles for the effective delivery of these silencers to the specific target locations has allowed researchers to overcome this issue. Particularly, gold nanoparticles (AuNPs) have been used as attractive vehicles for the target-specific delivery of gene-silencing moieties, alone or in combination with other drugs. We shall discuss current trends in AuNP-based delivery of gene-silencing tools, considering the promising road ahead without overlooking existing concerns for their translation to clinics.

Original languageEnglish
Article number94
JournalVirus Genes
Issue number3
Publication statusPublished - 1 Mar 2017



  • Combinatory therapy
  • Gene silencing
  • Gold nanoparticles
  • Interfering RNA
  • Nanotechnology

Cite this